CLINICAL PHARMACOLOGY OF PSYCHOTROPIC DRUGS

ORIGINAL SOURCE
Originally published in Multidisciplinary Journal of Science and Technology; Vol. 4 No. 1 (2024): MULTIDISCIPLINARY JOURNAL OF SCIENCE AND TECHNOLOGY; 135-137.

Pirmatov, Shohrux and Xojiyev, bahrom and Chariev, Muzaffar (2024) CLINICAL PHARMACOLOGY OF PSYCHOTROPIC DRUGS. Multidisciplinary Journal of Science and Technology; Vol. 4 No. 1 (2024): MULTIDISCIPLINARY JOURNAL OF SCIENCE AND TECHNOLOGY; 135-137.

[thumbnail of 1946.pdf] PDF
1946.pdf - Published Version

Download (673kB)

Abstract

There are many reasons why once a day oral dosage may be advantageous in administration of psychotropic drugs to mental patients, such as convenience for the patient, avoided side effects, ease of remembering, all of which contribute to reliable dosage as well as cost savings. This paper illustrates cost data, pharmacokinetics of psychotropic drugs, and suggests a basis for determining adequate pill size for unit dosage. On a cost per milligram basis, there is economic savings if medication is prescribed in the largest size the patient can conveniently take. Pharmacological data support a rationale for higher unit dosage. They indicate a dose response relationship between dose and therapeutic effectiveness and probably a blood level relationship. The long half-life indicates that once-a-day medication is a reasonable dosage schedule. The most important evidence for once-a-day medication, however, is the empirical evidence that it works, and is safe. Dosage information from double blind investigations provides a basis for determining adequacy of pill size for antipsychotic therapy.

Item Type: Article
Additional Information: Imported from Multidisciplinary Journal of Science and Technology
SWORD Depositor: Admin User
Depositing User: Admin User
Date Deposited: 24 Sep 2026 22:42
Last Modified: 24 Sep 2026 22:42
URI: https://universalpublishings.uz/id/eprint/9328

Actions (login required)

View Item
View Item